The cavity has a volume of ~370 3 , notably larger than that of carnitine, which we estimate at ~150 3
The consequences are significant: analytical granularity is lost, cross-national comparisons become less meaningful, and classification-based drug surveillance, even for defined drug classes, becomes unreliable
Lmites: En el cromatograma de la solucin de muestra, si hay un pico cromatogrfico con el mismo tiempo de retencin que el pico de impureza I, calcular por el mtodo del patrn externo basado en el rea del pico
Subgroup analysis for treatment durations 6 months indicated a higher WL in the GLP-1RAs group (SMD = 0.79, 95% CI 0.25 to 1.34)
Kathryn Kline explains DEXA screening, T-scores, and the treatments that actually prevent fractures
Clinical trials are still needed to validate their safety and efficacy in human patients before they can be widely used in AD therapy